Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● With a P/E ratio at 10.36 for the current year and 9.68 for next year, earnings multiples are highly attractive compared with competitors.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● The company is one of the best yield companies with high dividend expectations.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

● Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

● The group usually releases upbeat results with huge surprise rates.


Weaknesses

● With an enterprise value anticipated at 3.84 times the sales for the current fiscal year, the company turns out to be overvalued.